Pharmaceutical industry responds slowly to NHS
The pharmaceutical industry is responding too slowly to changes in the health service to meet the needs of today’s NHS, the results of a study suggest.
Market information group Taylor Nelson Sofres questioned heads of medicines
management and prescribing at primary care trusts, GPs and patient groups
on behalf of Takeda UK. Most PCT leads thought that pharmaceutical companies
were still operating as they had five to 10 years ago. Three-quarters
of PCT leads believed that pharmaceutical companies should avoid a purely
product-focused approach and 80 per cent thought that they should work
in partnership with primary care organisations to develop local strategies
to meet local needs.
Respondents also questioned whether traditional sales representatives
could meet the requirements of the modern NHS: 45 per cent of PCT leads
and 40 per cent of GPs believed that their knowledge of new products
would be unaffected if they never saw another pharmaceutical sales representative. |
The
Pharmaceutical Journal
Acrobat
Reader